Cargando…

Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1

Human ALC1 is an oncogene-encoded chromatin-remodeling enzyme required for DNA repair that possesses a poly(ADP-ribose) (PAR)-binding macro domain. Its engagement with PARylated PARP1 activates ALC1 at sites of DNA damage, but the underlying mechanism remains unclear. Here, we establish a dual role...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehmann, Laura C., Hewitt, Graeme, Aibara, Shintaro, Leitner, Alexander, Marklund, Emil, Maslen, Sarah L., Maturi, Varun, Chen, Yang, van der Spoel, David, Skehel, J. Mark, Moustakas, Aristidis, Boulton, Simon J., Deindl, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745148/
https://www.ncbi.nlm.nih.gov/pubmed/29220652
http://dx.doi.org/10.1016/j.molcel.2017.10.017
_version_ 1783288865756282880
author Lehmann, Laura C.
Hewitt, Graeme
Aibara, Shintaro
Leitner, Alexander
Marklund, Emil
Maslen, Sarah L.
Maturi, Varun
Chen, Yang
van der Spoel, David
Skehel, J. Mark
Moustakas, Aristidis
Boulton, Simon J.
Deindl, Sebastian
author_facet Lehmann, Laura C.
Hewitt, Graeme
Aibara, Shintaro
Leitner, Alexander
Marklund, Emil
Maslen, Sarah L.
Maturi, Varun
Chen, Yang
van der Spoel, David
Skehel, J. Mark
Moustakas, Aristidis
Boulton, Simon J.
Deindl, Sebastian
author_sort Lehmann, Laura C.
collection PubMed
description Human ALC1 is an oncogene-encoded chromatin-remodeling enzyme required for DNA repair that possesses a poly(ADP-ribose) (PAR)-binding macro domain. Its engagement with PARylated PARP1 activates ALC1 at sites of DNA damage, but the underlying mechanism remains unclear. Here, we establish a dual role for the macro domain in autoinhibition of ALC1 ATPase activity and coupling to nucleosome mobilization. In the absence of DNA damage, an inactive conformation of the ATPase is maintained by juxtaposition of the macro domain against predominantly the C-terminal ATPase lobe through conserved electrostatic interactions. Mutations within this interface displace the macro domain, constitutively activate the ALC1 ATPase independent of PARylated PARP1, and alter the dynamics of ALC1 recruitment at DNA damage sites. Upon DNA damage, binding of PARylated PARP1 by the macro domain induces a conformational change that relieves autoinhibitory interactions with the ATPase motor, which selectively activates ALC1 remodeling upon recruitment to sites of DNA damage.
format Online
Article
Text
id pubmed-5745148
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-57451482018-01-02 Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1 Lehmann, Laura C. Hewitt, Graeme Aibara, Shintaro Leitner, Alexander Marklund, Emil Maslen, Sarah L. Maturi, Varun Chen, Yang van der Spoel, David Skehel, J. Mark Moustakas, Aristidis Boulton, Simon J. Deindl, Sebastian Mol Cell Article Human ALC1 is an oncogene-encoded chromatin-remodeling enzyme required for DNA repair that possesses a poly(ADP-ribose) (PAR)-binding macro domain. Its engagement with PARylated PARP1 activates ALC1 at sites of DNA damage, but the underlying mechanism remains unclear. Here, we establish a dual role for the macro domain in autoinhibition of ALC1 ATPase activity and coupling to nucleosome mobilization. In the absence of DNA damage, an inactive conformation of the ATPase is maintained by juxtaposition of the macro domain against predominantly the C-terminal ATPase lobe through conserved electrostatic interactions. Mutations within this interface displace the macro domain, constitutively activate the ALC1 ATPase independent of PARylated PARP1, and alter the dynamics of ALC1 recruitment at DNA damage sites. Upon DNA damage, binding of PARylated PARP1 by the macro domain induces a conformational change that relieves autoinhibitory interactions with the ATPase motor, which selectively activates ALC1 remodeling upon recruitment to sites of DNA damage. Cell Press 2017-12-07 /pmc/articles/PMC5745148/ /pubmed/29220652 http://dx.doi.org/10.1016/j.molcel.2017.10.017 Text en © 2017 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lehmann, Laura C.
Hewitt, Graeme
Aibara, Shintaro
Leitner, Alexander
Marklund, Emil
Maslen, Sarah L.
Maturi, Varun
Chen, Yang
van der Spoel, David
Skehel, J. Mark
Moustakas, Aristidis
Boulton, Simon J.
Deindl, Sebastian
Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1
title Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1
title_full Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1
title_fullStr Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1
title_full_unstemmed Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1
title_short Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1
title_sort mechanistic insights into autoinhibition of the oncogenic chromatin remodeler alc1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745148/
https://www.ncbi.nlm.nih.gov/pubmed/29220652
http://dx.doi.org/10.1016/j.molcel.2017.10.017
work_keys_str_mv AT lehmannlaurac mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT hewittgraeme mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT aibarashintaro mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT leitneralexander mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT marklundemil mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT maslensarahl mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT maturivarun mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT chenyang mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT vanderspoeldavid mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT skeheljmark mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT moustakasaristidis mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT boultonsimonj mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1
AT deindlsebastian mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1